Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001322465 | SCV001513339 | pathogenic | EGFR-related lung cancer | 2024-07-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys187Leufs*2) in the EGFR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EGFR are known to be pathogenic (PMID: 7630400, 28726809, 29899996). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with neonatal inflammatory skin and bowel disease (PMID: 28726809). This variant is also known as c.560-2_565delAGGCCAAA. ClinVar contains an entry for this variant (Variation ID: 1022540). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |